company

Amgen

Biotechnology / Biopharmaceuticals
78Good
Aio Composite Score
Confidence
ApplicationHeavy
high
ImpactNeutral
medium
OpennessTransparent
medium
Amgen is an aggressive AI adopter deploying generative AI, machine learning, and autonomous agents across R&D, manufacturing, patient access, and administrative functions enterprise-wide. The company has rolled out Microsoft Copilot to 20,000 employees, partnered with OpenAI on ChatGPT Enterprise and GPT-5 evaluation, and built custom AI agents for drug discovery, manufacturing quality inspection, and benefit verification. Amgen maintains a publicly articulated AI governance framework aligned to NIST Trustworthy AI standards, with human oversight signals present across multiple documented use cases. Reported layoffs appear linked to post-acquisition restructuring and drug pricing pressures rather than AI-driven displacement, with no direct causal evidence connecting AI adoption to workforce reductions.
Application
How is AI being used?
Heavy
high
Amgen has deployed generative AI at scale across manufacturing, R&D, patient services, and enterprise productivity — including 20,000 Copilot seats,…
Impact
How have people been affected?
Neutral
medium
Documented layoffs are attributed by company and press reporting to post-acquisition restructuring and drug pricing pressures, not AI automation; no…
Openness
Company honesty about AI use.
Transparent
medium
Amgen's public narrative about AI — aggressive adoption, named tools and vendors, published governance framework, named AI council, and specific use…
AI Tools & Platforms Detected
Microsoft CopilotMicrosoft Copilot StudioChatGPT Enterprise (OpenAI)GPT-5 (OpenAI evaluation)NVIDIA AI models / DGX SuperPOD (Freyja)Amazon SageMakerAWS generative AI solutionsInfinitus Systems Eva (AI benefit verification agent)Catalyst Copilot (custom internal tool)LangChainSemantic KernelRAG pipelines / vector databases
AI Hiringmoderate
30AI roles/ 1114 total
Amgen Science Fellow - Computational Biology, AI, and Advanced ComputingMachine Learning Engineer AI/ML (US Remote)Sr Machine Learning Engineer AI/ML (US Remote)Associate Director, Machine Learning EngineerResponsible AI Manager
Key Evidence (11)
Amgen rolled out Microsoft Copilot to 20,000 employees enterprise-wide as an early adopter of generative AI productivity tools
2024-05
web searchSource ↗
Amgen was an early adopter of ChatGPT Enterprise; access was phased and scaled across the company as capabilities improved, and the company evaluated GPT-5 as part of its OpenAI collaboration
2025-08
web searchSource ↗
Amgen built Catalyst Copilot using Microsoft Copilot Studio to ingest and reason over internal knowledge resources for drug developers, with a Q&A interface
web searchSource ↗
Amgen deployed Eva, an AI agent from Infinitus Systems, for benefit verification; Eva identifies itself as automated, always offers a human escalation option, and all outputs are reviewed by trained Amgen staff
2025-11
web searchSource ↗
95% of syringes and vials are released through automated AI-based visual inspection in manufacturing, following multi-year FDA validation process
2024-09-03
web searchSource ↗
Amgen published a formal Artificial Intelligence Vision committing to AI Assurance and Security Assurance, and established an AI Governance Council aligned to NIST Trustworthy AI framework
web searchSource ↗
What insider reports could clarify
  • Have any specific job functions or teams been reduced because AI tools now perform those tasks?
  • How are AI-generated drug discovery candidate outputs reviewed before advancing to lab testing?
  • Do manufacturing workers have the ability to override or flag AI visual inspection decisions?
  • How does Amgen's AI Governance Council handle disagreements between business units and compliance on AI deployments?
  • Have employees noticed changes in workload or job scope since Copilot and ChatGPT Enterprise were rolled out?
Submit a ReportClaim This Profile